Mindfulness-Based Approaches to Insomnia

Sponsor
Rush University Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT00768781
Collaborator
Stanford University (Other), University of Toronto (Other)
54
1
3
53
1

Study Details

Study Description

Brief Summary

The overall goal of this project is to evaluate the evidence for the efficacy of two mindfulness-based interventions, mindfulness-based therapy for insomnia (MBT-I) and mindfulness-based stress reduction (MBSR), for reducing arousal and improving sleep among individuals with psychophysiological insomnia.

Specific Aim 1: To obtain evidence for the relative effects of MBT-I and MBSR compared to a delayed-treatment control condition followed by behavior therapy for insomnia (BT-I) on arousal levels. It is hypothesized that MBSR and MBT-I will be superior to the control condition at reducing arousal levels.

Specific Aim 2: To obtain evidence for the relative effects of MBT-I, MBSR, and the delayed-treatment control on sleep. It is hypothesized that MBT-I will be superior to the MBSR and control conditions at improving sleep parameters.

Specific Aim 3: To investigate the relationship between measures of arousal (self-report and objective measures) and sleep (self-report and objective measures) to enhance the understanding of the role of arousal in psychophysiological insomnia.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mindfulness-Based Stress Reduction
  • Behavioral: Mindfulness-Based Therapy for Insomnia
  • Behavioral: Wait-List + Behavioral Therapy for Insomnia
Phase 2

Detailed Description

The conceptual model for this study identifies two possible targets of treatment: arousal and sleep. In this model, BT for insomnia directly targets nighttime symptoms of insomnia (BT pathway), which improves sleep by increasing the homeostatic drive for sleep. Although BT is hypothesized to indirectly reduce arousal, no study has specifically investigated this effect. In contrast, MBSR is an intervention that is hypothesized to target arousal and, as preliminary findings suggest, also improves some symptoms of insomnia (MBSR pathway). It is therefore hypothesized that a combination of BT and mindfulness is superior to each treatment alone as it targets both nighttime symptoms and hyperarousal (Mindfulness + BT pathway). Our preliminary data suggests that this combination treatment has effects on both self-reported arousal and sleep. Conceptually, this novel approach would provide a set of self-regulating skills that could potentially target a broader range of daytime and nighttime symptoms that is characteristic of an insomnia disorder.

To test the conceptual model, this study employs a randomized clinical trial design with three conditions: 1) Mindfulness-Based Therapy for insomnia (MBT-I), 2) mindfulness-based stress reduction (MBSR), and 3) delayed-treatment condition followed by behavior therapy for insomnia (BT-I). Each of the three treatments will be delivered in a group format with 8 weekly sessions spanning an 8-week period.

Study Design

Study Type:
Interventional
Actual Enrollment :
54 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Augmenting Behavior Therapy for Insomnia With Mindfulness Meditation
Study Start Date :
Nov 1, 2008
Actual Primary Completion Date :
Nov 1, 2012
Actual Study Completion Date :
Apr 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Mindfulness-Based Stress Reduction

Behavioral: Mindfulness-Based Stress Reduction
The rationale for treatment is that MBSR targets arousal, which is a prominent perpetuating factor of insomnia. Each session meets weekly for 120 minutes and consists of a therapist-led mindfulness meditation, followed by a discussion of the meditation and its application into the participant's everyday life. For homework, each participant is required to practice formal meditation at least 45 minutes a day, 6 days per week. Participants will be provided a tape, an mp3 file, or CD to aid in the participant's personal practice at home. Formal meditations that will be led and discussed include eating meditation, body scan, sitting meditation, Hatha Yoga, and walking meditation. In addition, informal mindfulness practices will be discussed.

Active Comparator: Mindfulness-Based Therapy for Insomnia

Behavioral: Mindfulness-Based Therapy for Insomnia
MBTI treatment includes the hypothesized active elements of both mindfulness meditation and behavior therapy for insomnia. The intervention includes 8 weekly sessions. Each session meets weekly for approximately 120 minutes. The general format of each session includes formal mindfulness meditation (quiet and movement meditations) and instructions for the behavioral intervention, with a focus on integrating the principles of mindfulness with these instructions. Each participant is required to practice formal meditation for at least 45 minutes a day, 6 days per week as homework. Participants are provided a tape, mp3 file, or CD to aid in the participant's personal practice at home.

Other: Behavioral Therapy for Insomnia (Delayed treatment condition)

Behavioral: Wait-List + Behavioral Therapy for Insomnia
This delayed treatment condition consists of an 8-week monitoring period (sleep diaries, PSAS) and then BT. The BT treatment consists of 8 sessions of behavioral interventions for insomnia, with instructions targeting the nighttime symptoms of insomnia. The primary components of this treatment package are stimulus control, sleep restriction, and sleep hygiene education. In the BT condition, each weekly session lasts 120 minutes and consists of formal instructions for the behavioral interventions along with a time for discussion of the application of these instructions into each participant's unique circumstances.

Outcome Measures

Primary Outcome Measures

  1. Pre-Sleep Arousal Scale (PSAS) total score [Baseline, during txt, post-txt, 3 month follow-up, 6 month follow-up]

  2. Sleep Diaries (Total Wake Time) [Baseline, post-txt, 6 month follow-up]

Secondary Outcome Measures

  1. Actigraphy measures of sleep/wake time [Baseline, during txt, post-txt, 3 month follow-up, 6 month follow-up]

  2. Polysomnographic measures of sleep parameters [Baseline, post-txt, 6 month follow-up]

  3. Insomnia Severity Index (ISI) total score [Baseline, post-txt, 3 month follow-up, 6 month follow-up]

  4. Five Factor Questionnaire (Mindfulness Skills) Total score [Baseline, post-txt, 3 month follow-up, 6 month follow-up]

  5. Dysfunctional Beliefs and Attitudes about Sleep (DBAS) score [Baseline, post-txt, 3 month follow-up, 6 month follow-up]

  6. Hyperarousal Scale (HAS) score [Baseline, post-txt, 3 month follow-up, 6 month follow-up]

  7. Heart Rate variability (HR) [Baseline, post-treatment, 6-month follow-up]

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Meets criteria for psychophysiological insomnia

  • Males and females of age 21 or older

Exclusion Criteria:
  • Unstable medical condition that is known to impact sleep

  • Psychiatric conditions likely to impact the practice of meditation

  • Current active suicidal ideation

  • Presence of a primary sleep disorder other than primary insomnia

  • Evidence of paradoxical insomnia

  • Evidence of idiopathic insomnia

  • Frequent use of alcohol at bedtime

  • Excessive daily caffeine consumption

  • Current use of sleep medications on a regular basis

  • Inadequate proficiency in English

  • Inability to commit to attending therapy sessions due to schedule conflicts

  • Women who are pregnant

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sleep Disorders Center, Rush University Medical Center Chicago Illinois United States 60612

Sponsors and Collaborators

  • Rush University Medical Center
  • Stanford University
  • University of Toronto

Investigators

  • Principal Investigator: Jason C Ong, PhD, Rush University Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jason C. Ong, PhD, Assistant Professor, Rush University Medical Center
ClinicalTrials.gov Identifier:
NCT00768781
Other Study ID Numbers:
  • K23AT003678
  • K23AT003678
First Posted:
Oct 8, 2008
Last Update Posted:
May 30, 2013
Last Verified:
May 1, 2013
Keywords provided by Jason C. Ong, PhD, Assistant Professor, Rush University Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 30, 2013